BRIEF-Amgen and Allergan submit biosimilar marketing authorization
December 02, 2016 at 09:19 AM EST
* Amgen and Allergan submit biosimilar marketing authorization application to european medicines agency for ABP 215, a biosimilar candidate to bevacizumab
